Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Ceftazidime-Avibactam versus Colistin in Critically Ill Patients with Carbapenem-Resistant Enterobacteriaceae Infections (AVI-ICU): A Randomized Clinical Trial | King Faisal Specialist Hospital & Research Centre | Ongoing | Ceftazidime-avibactam | 3 | 2211247 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating The Efficiacy And Safety Of Crovalimab Versus Eculizumab In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated with Complement Inhibitors | Roche | Ongoing | Crovalimab | 3 | BO42161 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating The Efficiacy And Safety Of Crovalimab Versus Eculizumab In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors | Roche | Completed | Crovalimab | 3 | BO42162 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in Subjects with Multiple Myeloma (CARTITUDE-2) | Janssen-Cilag International NV | Ongoing | Carvkti | 2 | 68284528MMY2003 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Minimal Effective Concentration of Lidocaine in Propofol Lidocaine Mixture for Relief of Pain on Propofol Injection | King Fahd University Hospital | Rejected | lidocaine | 4 | IRB-2020-3 | King Fahad University Hospital (Al-Khobar) |
| A Prospective, Multicenter, Single-Arm, Open-Label, Phase 3 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging. (RESTORE) | Selexipag | Completed | Selexipag | 3 | 67896049PAH4005 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A randomised, double-blind, placebo-controlled trial of erythropoietin alfa versus placebo in mechanically ventilated critically ill patients following traumatic injury | KAIMRC/Australian and New Zealand Intensive Care Research Centre | Ongoing | Epoetin Alfa (Recombinant Human Erythropoietine) (EPREX) | 3 | EPO-TRAUMA ANZIC-RC/CF001 - CT20/046/R | King Abdulaziz Medical City NG (Riyadh) |
| An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial | Global Blood Therapeutics (GBT) | Ongoing | Inclacumab | 3 | GBT2104-133 | Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises | Global Blood Therapeutics (GBT) | Completed | Inclacumab | 3 | GBT2104-132 | Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi |
| Nucala Effectiveness Study (NEST) in Emerging Markets | King Fahd University Hospital | Completed | Mepolizumab | 3 | 213475 | King Fahad University Hospital (Al-Khobar) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.